Estimating 5-year risk of CIN3+ to guide the management of women aged 21–24

OBJECTIVE: Current US national guidelines recommend beginning screening at age 21 using Pap tests only, with cotesting starting at age 30. To inform the management of Pap test abnormalities among women aged 21–24, who have extremely low cancer risks, we compared risks of CIN3+ for women aged 21–24 v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Katki, Hormuzd A., Schiffman, Mark, Castle, Philip E., Fetterman, Barbara, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Raine-Bennett, Tina, Gage, Julia C., Kinney, Walter K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616448/
https://ncbi.nlm.nih.gov/pubmed/23519307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/LGT.0b013e3182854399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados